Action initiated against internet selling of Schedule ‘H’ medicines

Mumbai

The state government had informed the Bombay High Court that an action has been initiated against nine websites for selling drugs online. These are among 86 sites identified as being involved in sale of Schedule ‘H’ medicines that otherwise require prescriptions. The government  has started cancelling licenses of suppliers. The court was hearing a public interest litigation (PIL) seeking a ban on sale of Schedule ‘H’ medicines online without prescriptions or cash memos. The government said that their own officers had tried to place orders online and had then contacted the cyber crime cell of the police to block sites found selling such medicines without prescription. Government pleader P P Kakade said, ‘many of the websites were registered abroad. Out of 86 websites identified by us, 44 operate in India and we have taken action against nine. In such cases, when we tried to contact the websites, there was no confirmation or response. The suppliers to such websites have also been served show cause notices and their licenses were cancelled,”. The HC, while saying that the government had made a good beginning, asked them to strengthen action. “You should also create awareness amongst customers that buying medicines without prescription is not permissible,” said the court.”The office of the Drug Controller General of India has communicated on the present subject to all states. A sub-committee headed by commissioner FDA, Maharashtra, has been formed to keep strict vigil and take strict action against violation of rules. The state authority should take up a public awareness programme and ensure strict vigilance of online sale of medicines,” said the bench.Justices N H Patil and A A Sayed were hearing a PIL filed by a Mumbai college lecturer Mayuri Patil, through her lawyer Vallari Jathar. The whole process of supplying medicines by websites is in violation of the Medicines and Cosmetics Rules,1945, says the PIL.


  • Related Posts

    NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

    The officials identified the substance as Alprazolam manufactured illegally at the lab. HYDERABAD: In one of the largest such seizures in recent times, the Narcotics Control Bureau (NCB), Hyderabad, raided…

    Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

    New Delhi: The Ministry of AYUSH has detailed its regulatory framework and ongoing initiatives to monitor heavy metal content in traditional medicines, responding to parliamentary concerns over quality and safety…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Commissioner FDA reviews enforcement measures

    Commissioner FDA reviews enforcement measures

    Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

    Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

    Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

    Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

    CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

    CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

    Piramal Pharma Gets 3 USFDA Observations at US Facility

    Piramal Pharma Gets 3 USFDA Observations at US Facility

    Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

    Eli Lilly pauses Indian obesity awareness campaign after regulatory notices